JPS5758696A - Macrolide compound - Google Patents

Macrolide compound

Info

Publication number
JPS5758696A
JPS5758696A JP56119031A JP11903181A JPS5758696A JP S5758696 A JPS5758696 A JP S5758696A JP 56119031 A JP56119031 A JP 56119031A JP 11903181 A JP11903181 A JP 11903181A JP S5758696 A JPS5758696 A JP S5758696A
Authority
JP
Japan
Prior art keywords
macrolide compound
macrolide
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56119031A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0428710B2 (en, 2012
Inventor
Toomasu Seno Yuujiin
Henrii Barutsu Richiyaado
Eru Hamiru Robaato
Miyurieru Wairudo Jiin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS5758696A publication Critical patent/JPS5758696A/ja
Publication of JPH0428710B2 publication Critical patent/JPH0428710B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/08Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • C12R2001/54Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
JP56119031A 1980-07-29 1981-07-28 Macrolide compound Granted JPS5758696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,312 US4299953A (en) 1980-07-29 1980-07-29 Mycarosyltylactone

Publications (2)

Publication Number Publication Date
JPS5758696A true JPS5758696A (en) 1982-04-08
JPH0428710B2 JPH0428710B2 (en, 2012) 1992-05-15

Family

ID=22631450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56119031A Granted JPS5758696A (en) 1980-07-29 1981-07-28 Macrolide compound

Country Status (6)

Country Link
US (1) US4299953A (en, 2012)
JP (1) JPS5758696A (en, 2012)
CA (1) CA1181746A (en, 2012)
CS (1) CS228517B2 (en, 2012)
PH (1) PH16087A (en, 2012)
ZA (1) ZA815183B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61185124U (en, 2012) * 1986-04-03 1986-11-18

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419508A (en) * 1980-11-10 1983-12-06 Eli Lilly And Company 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production
US4401660A (en) * 1981-12-14 1983-08-30 Eli Lilly And Company Ester derivatives of 5-O-mycaminosyl tylonolide and method of using same
US4423148A (en) * 1982-07-02 1983-12-27 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4436729A (en) 1982-06-30 1984-03-13 Schering Corporation 23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use
US4528369A (en) * 1982-07-02 1985-07-09 Eli Lilly And Company 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
US4552701A (en) * 1984-04-16 1985-11-12 Eli Lilly And Company Glycopeptide antibiotics and process of preparation
EP0343776A3 (en) * 1988-03-28 1991-04-17 Eli Lilly And Company Method for producing 20-deoxotylosin
KR100914251B1 (ko) 2007-06-27 2009-08-26 이화여자대학교 산학협력단 신규한 올리보실 틸락톤 및 그 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
US3344024A (en) * 1963-04-17 1967-09-26 American Cyanamid Co Antibiotic am-684 and method of production
BE667952A (en, 2012) * 1964-08-05
US4161523A (en) * 1972-11-15 1979-07-17 Schering Corporation Rosamicin esters, acid addition salts and methods for production thereof
CH619267A5 (en, 2012) * 1975-08-01 1980-09-15 Sanraku Ocean Co
US4056616A (en) * 1976-03-05 1977-11-01 Schering Corporation Rosamicin derivatives and method of using same
GB1587685A (en) * 1977-03-09 1981-04-08 Microbial Chem Res Found Macrolactone derivatives and their production
US4205163A (en) * 1977-11-08 1980-05-27 Sanraku-Ocean Co., Ltd. Tylosin derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61185124U (en, 2012) * 1986-04-03 1986-11-18

Also Published As

Publication number Publication date
CS228517B2 (en) 1984-05-14
JPH0428710B2 (en, 2012) 1992-05-15
CA1181746A (en) 1985-01-29
US4299953A (en) 1981-11-10
PH16087A (en) 1983-06-20
ZA815183B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
DE3160084D1 (en) Novel erythromycin compounds
GB2081717B (en) Hereocyclic compounds
SG69286G (en) 4-chlorothiazolyl-containing compounds
JPS5731699A (en) Macrolide antibiotic
JPS56169126A (en) Improvement on compound
JPS5767568A (en) Benzisoselenazolone compound
JPS57120588A (en) Nortropanol compound
JPS57120575A (en) Imidazolylphenylamidine compound
DE3171475D1 (en) Aryl-phenyl-acetylene compounds
JPS5724328A (en) Dienylmethacrylate compound
JPS5758696A (en) Macrolide compound
GB2083046B (en) Bestatin-related compounds
PT72752B (en) Compounds
JPS5749666A (en) Helichromic compound
JPS56152469A (en) Substituted triarylthiazole compound
GB2067992B (en) Malonamidooxadethiacephem compounds
JPS5795972A (en) 2-guanidino-4-heteroarylthiazole compound
JPS5794051A (en) Halotriazinyl-containing compound
JPS56125389A (en) Spiro-dihydrobenzofuran compound
DE3162041D1 (en) Hydrouracil compounds
ZA812675B (en) Mycotoxin-binding compound
GB2082577B (en) Polyazaheterocyclic compounds
JPS5781488A (en) 1-oxa-beta-lactam antibiotic
DE3173028D1 (en) Antibiotic a-4696 factor g
ZA814789B (en) Macrolide antibioties